Paul Oskar III has joined MPI Research as vice president, general manager of Drug Safety and Preclinical Sciences. During the past decade, Mr. Oskar has held numerous leadership positions with Charles River Laboratories (CRL), most recently as corporate vice president, Global Primate Supply. At CRL, he has also held the positions of corporate vice president of Global Discovery Services, corporate vice president of Specialty Preclinical Services, corporate vice president and president of U.S. Preclinical Services, and general manager of Preclinical Services at CRL’s Worcester site.

He began his career at CRL’s Research Animal Diagnostic Services Laboratory, ultimately serving as executive director responsible for all laboratory operations. During his time at CRL, Mr. Oskar consistently grew sales and profits, expanded laboratory space and implemented cutting edge technology, according to an MPI statement.

Tim Derrington, MPI Research’s president and chief operating officer, commented, “Paul has the robust experience in CRO management that will even further strengthen the industry footprint and operating capabilities of MPI Research. His proven success in implementing new technologies and capital project management, and his extensive background in building operational efficiencies and other key corporate functions will add breadth and depth to our leadership team, and enable us to continue to meet the expectations of our growing customer base.”